Authors:
Hindmarch, I
Patat, A
Stanley, N
Paty, I
Rigney, U
Citation: I. Hindmarch et al., Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening, HUM PSYCHOP, 16(2), 2001, pp. 159-167
Authors:
Patat, A
Rosenzweig, P
Enslen, M
Trocherie, S
Miget, N
Bozon, MC
Allain, H
Gandon, JM
Citation: A. Patat et al., Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects, HUM PSYCHOP, 15(3), 2000, pp. 153-170
Citation: P. Rosenzweig et A. Patat, Lack of behavioural toxicity of mizolastine: a review of the clinical pharmacology studies, CLIN EXP AL, 29, 1999, pp. 156-162
Authors:
Patat, A
Rosenzweig, P
Miget, N
Allain, H
Gandon, JM
Citation: A. Patat et al., Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions inhealthy sleep-deprived subjects, FUN CL PHAR, 13(5), 1999, pp. 582-594
Authors:
Patat, A
Chaufour, S
Gandon, JM
Allain, H
Rosenzweig, P
Citation: A. Patat et al., Safety and pharmacodynamics of single ascending doses of SL34.0026, a new reversible and selective MAO-B inhibitor in healthy subjects, BR J CL PH, 47(5), 1999, pp. 584-585
Authors:
Ramaekers, JG
Louwerens, JW
Muntjewerff, ND
Milius, H
de Bie, A
Rosenzweig, P
Patat, A
O'Hanlon, JF
Citation: Jg. Ramaekers et al., Psychomotor, cognitive, extrapyramidal, and affective functions of healthyvolunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic, J CL PSYCH, 19(3), 1999, pp. 209-221